The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Company profile

CRISPR Therapeutics AG insider acquisitions

Company CIK 0001674416 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
CRSP · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 23, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate
7-day company acquisitions grouped by security, category, original code, and currency.
Type / codeReported securityTransactionsKnown purchase valueMissing amounts
Stock awardCode ARestricted Stock UnitsDerivative · Currency not specified1Not applicable0

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Silver Andrew JacobSilver Andrew JacobKulkarni SamarthKulkarni SamarthGeorge SimeonGeorge SimeonKASINGER JAMES R.KASINGER JAMES R.Silver Andrew Jacob · October 19, 2026 · Stock award · Restricted Stock UnitsKulkarni Samarth · October 16, 2026 · Exercise / conversion · Common SharesGeorge Simeon · October 14, 2026 · Exercise / conversion · Common SharesKASINGER JAMES R. · October 13, 2026 · Exercise / conversion · Common SharesKulkarni Samarth · October 13, 2026 · Exercise / conversion · Common SharesKASINGER JAMES R. · October 6, 2026 · Exercise / conversion · Common SharesKulkarni Samarth · October 16, 2025 · Exercise / conversion · Common SharesKulkarni Samarth · October 13, 2025 · Exercise / conversion · Common SharesKASINGER JAMES R. · October 13, 2025 · Exercise / conversion · Common SharesOct 13, 2025Oct 19, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

9 dated transactions · 4 of 4 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Oct 19, 2026CRISPR Therapeutics AGRestricted Stock UnitsSilver Andrew JacobStock award
Oct 16, 2026CRISPR Therapeutics AGCommon SharesKulkarni SamarthExercise / conversion
Oct 14, 2026CRISPR Therapeutics AGCommon SharesGeorge SimeonExercise / conversion
Oct 13, 2026CRISPR Therapeutics AGCommon SharesKASINGER JAMES R.Exercise / conversion
Oct 13, 2026CRISPR Therapeutics AGCommon SharesKulkarni SamarthExercise / conversion
Oct 6, 2026CRISPR Therapeutics AGCommon SharesKASINGER JAMES R.Exercise / conversion
Oct 16, 2025CRISPR Therapeutics AGCommon SharesKulkarni SamarthExercise / conversion
Oct 13, 2025CRISPR Therapeutics AGCommon SharesKulkarni SamarthExercise / conversion
Oct 13, 2025CRISPR Therapeutics AGCommon SharesKASINGER JAMES R.Exercise / conversion

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

CRSP · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade:
Silver Andrew JacobChief Financial Officer
Stock awardRestricted Stock UnitsDerivative security · Code A25,0000Value: 0Currency not specifiedView ↗
Trade:
Kulkarni SamarthChief Executive Officer · Director
Exercise / conversionCommon SharesNon-derivative security · Code M100,000Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Exercise / conversionCommon SharesNon-derivative security · Code M30,00014Value: 420,000Currency not specifiedView ↗
Trade:
KASINGER JAMES R.General Counsel and Secretary
Exercise / conversionCommon SharesNon-derivative security · Code M2,113Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade:
Kulkarni SamarthChief Executive Officer · Director
Exercise / conversionCommon SharesNon-derivative security · Code M8,333Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade:
KASINGER JAMES R.General Counsel and Secretary
Exercise / conversionCommon SharesNon-derivative security · Code M1,99013.62Value: 27,103.8Currency not specifiedView ↗
Trade:
Kulkarni SamarthChief Executive Officer · Director
Exercise / conversionCommon SharesNon-derivative security · Code M100,000Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade:
Kulkarni SamarthChief Executive Officer · Director
Exercise / conversionCommon SharesNon-derivative security · Code M8,334Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade:
KASINGER JAMES R.General Counsel and Secretary
Exercise / conversionCommon SharesNon-derivative security · Code M2,114Not reported *Value: Not reportedCurrency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →